Transtheoretical Model Counseling in Postpartum Contraception

NCT07784738 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2026-08-25

No results posted yet for this study

Summary

The purpose of this study is to evaluate the effect of contraceptive method counseling offered to primiparous women between the ages of 18-45 in the postpartum period by motivational interviewing method based on the Transtheoretic model, on the use of contraceptive methods.

Conditions

  • Birth Control Behavior
  • Reproductive Health Attitude

Interventions

BEHAVIORAL

Effect of Transtheoretical Model-Based Counseling on Postpartum Contraceptive Uptake

The study included women aged 18-45 who had given birth for the first time (primiparous), were within 72 hours of delivery and at the stage of discharge, and were considering using a contraceptive method in the future. A total of 80 women meeting the sampling criteria were randomly assigned to either the intervention group (n=30) or the control group (n=50). Data collection forms were completed through face-to-face interviews. While the intervention group received contraceptive counseling based on the Transtheoretical Model, the control group received routine postpartum care services at the clinic. Contraceptive method usage was assessed via telephone at the 6- and 12-month marks for both groups, and at the end of the 12-month period, the "Contraceptive Methods Knowledge Test" (KYIBT) was administered to measure knowledge regarding contraceptive methods.

Sponsors & Collaborators

  • Istanbul University - Cerrahpasa

    lead OTHER

Principal Investigators

  • Nevin ŞAHİN · Danışman

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-12-21
Primary Completion
2024-06-11
Completion
2024-06-11

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07784738 on ClinicalTrials.gov